Literature DB >> 6477128

Interaction of estrone and estradiol with DNA and protein of liver and kidney in rat and hamster in vivo and in vitro.

M Caviezel, W K Lutz, U Minini, C Schlatter.   

Abstract

[6,7-3H] Estrone (E) and [6,7-3H]estradiol-17 beta (E2) have been synthesized by reduction of 6-dehydroestrone and 6-dehydroestradiol with tritium gas. Tritiated E and E2 were administered by oral gavage to female rats and to male and female hamsters on a dose level of about 300 micrograms/kg (54 mCi/kg). After 8 h, the liver was excised from the rats; liver and kidneys were taken from the hamsters. DNA was purified either directly from an organ homogenate or via chromatin. The radioactivity in the DNA was expressed in the units of the Covalent Binding Index, CBI = (mumol chemical bound per mol DNA-P)/(mmol chemical administered per kg b.w.). Rat liver DNA isolated via chromatin exhibited the very low values of 0.08 and 0.09 for E and E2, respectively. The respective figures in hamster liver were 0.08 and 0.11 in females and 0.21 and 0.18 in the males. DNA isolated from the kidney revealed a detectable radioactivity only in the female, with values of 0.03 and 0.05 for E and E2, respectively. The values for male hamster kidney were less than 0.01 for both hormones. The minute radioactivity detectable in the DNA samples does not represent covalent binding to DNA, however, as indicated by two sets of control experiments. (A) Analysis by HPLC of the nucleosides prepared by enzyme digest of liver DNA isolated directly or via chromatin did not reveal any consistent peak which could have been attributed to a nucleoside-steroid adduct. (B) All DNA radioactivity could be due to protein contaminations, because the specific activity of chromatin protein was determined to be more than 3,000 times higher than of DNA. The high affinity of the hormone to protein was also demonstrated by in vitro incubations, where it could be shown that the specific activity of DNA and protein was essentially proportional to the concentration of radiolabelled hormone in the organ homogenate, regardless of whether the animal was treated or whether the hormone was added in vitro to the homogenate.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6477128     DOI: 10.1007/bf00346046

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  25 in total

1.  Isolation and properties of structured chromatin from Guerin ascites tumour and rat liver.

Authors:  M Yaneva; G Dessev
Journal:  Eur J Biochem       Date:  1976-07-15

2.  Irreversible protein binding of norethisterone (norethindrone) epoxide.

Authors:  H Kappus; H M Bolt
Journal:  Steroids       Date:  1976-01       Impact factor: 2.668

3.  Assay of some endogenous and synthetic sex steroids for tumor-initiating activity in rat liver using the Solt-Farber system.

Authors:  J Schuppler; J Dammé; R Schulte-Hermann
Journal:  Carcinogenesis       Date:  1983       Impact factor: 4.944

4.  Carcinogen testing: current problems and new approaches.

Authors:  J H Weisburger; G M Williams
Journal:  Science       Date:  1981-10-23       Impact factor: 47.728

5.  Covalent binding of diethylstilbestrol to DNA in rat and hamster liver and kidney.

Authors:  W K Lutz; W Jaggi; C Schlatter
Journal:  Chem Biol Interact       Date:  1982-11       Impact factor: 5.192

6.  Mutagenicity assays of estrogenic hormones in mammalian cells.

Authors:  C Drevon; C Piccoli; R Montesano
Journal:  Mutat Res       Date:  1981-05       Impact factor: 2.433

7.  The biotransformation of 17 alpha-ethynyl[3H]estradiol in the rat: irreversible binding and biliary metabolites.

Authors:  J L Maggs; P S Grabowski; M E Rose; B K Park
Journal:  Xenobiotica       Date:  1982-10       Impact factor: 1.908

8.  The relevance of covalent binding to mouse liver DNA to the carcinogenic action of hexachlorocyclohexane isomers.

Authors:  P Sagelsdorff; W K Lutz; C Schlatter
Journal:  Carcinogenesis       Date:  1983-10       Impact factor: 4.944

9.  Formation of covalent adducts between cortisol and 16 alpha-hydroxyestrone and protein: possible role in the pathogenesis of cortisol toxicity and systemic lupus erythematosus.

Authors:  R Bucala; J Fishman; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

10.  Increased DNA binding of the estrogen receptor in an estrogen-resistant mammary cancer.

Authors:  P P Baskevitch; F Vignon; C Bousquet; H Rochefort
Journal:  Cancer Res       Date:  1983-05       Impact factor: 12.701

View more
  5 in total

1.  Quantitative evaluation of DNA binding data for risk estimation and for classification of direct and indirect carcinogens.

Authors:  W K Lutz
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

2.  Effect of inhalation exposure regimen on DNA binding potency of 1,2-dichloroethane in the rat.

Authors:  A Baertsch; W K Lutz; C Schlatter
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

3.  Trenbolone growth promotant: covalent DNA binding in rat liver and in Salmonella typhimurium, and mutagenicity in the Ames test.

Authors:  W K Lutz; R Deuber; M Caviezel; P Sagelsdorff; U Friederich; C Schlatter
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

Review 4.  Metabolism of stilbene estrogens and steroidal estrogens in relation to carcinogenicity.

Authors:  M Metzler
Journal:  Arch Toxicol       Date:  1984-07       Impact factor: 5.153

5.  The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites.

Authors:  H S Purba; J L Maggs; M L Orme; D J Back; B K Park
Journal:  Br J Clin Pharmacol       Date:  1987-04       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.